Patheon
Patheon invests in key sites to support continued growth
Global provider of drug development and delivery solutions to the pharmaceutical sector, Patheon, has revealed it is anticipating to invest approximately $45 million at key sites worldwide to meet growing customer demand more
Jul 3, 2017 10:47 AM News
Biopharmaceutical manufacturing agreement forged for production of CAEL-101
An agreement between Fortress Biotech subsidiary, Caelum Biosciences, and Patheon has been made that will involve the process development and cGMP production of CAEL-101 more
Jun 2, 2017 3:22 PM News
Patheon completes sterile expansion project
Global provider of drug development and delivery solutions to pharma and biopharma sectors, Patheon, has announced the completion of its expansion project at its Greenville site in North Carolina. more
May 9, 2017 11:30 AM News
To be continued: 5 ways continuous manufacturing adds value for pharma
Stephen Closs, VP, Global Technical Operations, Patheon explains continuous manufacturing as an enabling technology for quality by design – and highlights five ways it adds value for the pharmaceutical industry. more
Mar 21, 2017 8:50 AM News
Winning formula: Searching for the right formulation for oral solid dose applications
Anil Kane, Ph.D., MBA, executive director, global head of formulation sciences, pharmaceutical development services at Patheon on finding the right formulation for oral solid dose applications more
Jan 24, 2017 11:05 AM News
What changes are in store for pharmaceutical manufacturers?
Michael Lehmann, executive vice president, global sales & marketing, Patheon shares his views on the challenges ahead for the pharma sector and how they could mean greater opportunities ahead for pharmaceutical manufacturers more
Apr 29, 2016 9:09 AM Opinion
Bringing services closer to home for Patheon customers is key
Patheon explains the importance of mergers and acquisitions as the company strengthens its position in the sector. more
Jun 22, 2015 1:25 PM Opinion
Patheon buys IRIX Pharmaceuticals
Patheon, a provider of high-quality drug development and delivery is to acquire IRIX Pharmaceuticals, a company that specialises in difficult to manufacture Active Pharmaceutical Ingredient (API) needs. more
Mar 4, 2015 2:26 PM News
Interview: Quick learners
EPM speaks to the team at Quick to Clinic, an initiative offered by Patheon. more
Oct 24, 2014 10:00 AM Technology
DPx Holdings reaches definitive agreement to acquire Gallus BioPharmaceuticals
Following the transaction, Patheon’s biologic drug substance business will span four facilities in Europe, Australia and North America. more
Sep 4, 2014 1:04 PM
Patheon SVP Delivers Presentation on Improving Quality Performance
Patheon’s Harry Gill, Senior Vice President, Quality and Continuous Improvement, will be presenting ‘Transforming Quality Performance Using Common Operational Excellence Tools’ at INTERPHEX, 19 March, 3:15 pm, stage 2. more
Jan 20, 2014 3:44 PM Technology
Patheon Expands Offerings and Capacity at UK Facility
CDMO Patheon is increasing solid dose capabilities at its European sites. The latest investments are being made at the company’s Milton Park, UK, facility. This standalone early development centre will now offer automated capsule filling... more
Dec 3, 2013 4:52 PM Technology
Patheon SVP Delivers Presentation 'Utilising Operational Excellence Principles to Drive Quality Improvements'
Patheon’s Harry Gill, SVP, Quality and Continuous Improvement, will present 'Utilising Operational Excellence Principles to Drive Quality Improvements' on Wednesday 23 October at 2:30 p.m., CET on Stand 42L52. more
Oct 22, 2013 11:41 AM News
